Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.32USD
8 Dec 2016
Change (% chg)

$-0.05 (-3.65%)
Prev Close
$1.37
Open
$1.37
Day's High
$1.37
Day's Low
$1.32
Volume
6,227
Avg. Vol
21,079
52-wk High
$3.19
52-wk Low
$1.20

ACST.OQ

Chart for ACST.OQ

About

Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved in the development and commercialization of pharmaceutical applications of its licensed rights for... (more)

Overall

No Ratios Available.

Financials

  ACST.OQ Industry Sector
P/E (TTM): -- 30.04 30.65
EPS (TTM): -- -- --
ROI: -- 15.86 15.23
ROE: -- 16.96 16.56

BRIEF-Acasti Pharma appoints Linda O'keefe as chief financial officer

* Acasti Pharma appoints Linda O'keefe as chief financial officer

Nov 28 2016

Earnings vs. Estimates